Atlas Trials

A Phase 2 Study to Evaluate the Safety and Efficacy of CB-03-01 Solution, a Comparator Solution and Vehicle Solution in Males With Androgenetic Alopecia

Clinical trial NCT02279823 · COMPLETED

Trial details

NCT number
NCT02279823
Sponsor
Intrepid Therapeutics, Inc.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Androgenetic Alopecia
Start date
2014-10-01
Primary completion
2015-12-01
Enrollment
95

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.